Patients' perspectives on actinic keratosis

Current Problems in Dermatology (Switzerland)

Volumn 46, Issue , 2015, Pages 8-13

  Esmann, Solveig ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ACTINIC KERATOSIS; ARTICLE; ATTITUDE TO ILLNESS; BODY IMAGE; COPING BEHAVIOR; COST OF ILLNESS; HUMAN; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION EXPOSURE; SCAR FORMATION; SELF ESTEEM; SKIN IRRITATION; SOCIAL BEHAVIOR; SOCIAL LIFE; ULTRAVIOLET RADIATION; ADAPTIVE BEHAVIOR; ATTITUDE TO HEALTH; HEALTH BEHAVIOR; KERATOSIS, ACTINIC; PSYCHOLOGY; SKIN NEOPLASMS; SQUAMOUS CELL CARCINOMA;

ADAPTATION, PSYCHOLOGICAL; CARCINOMA, SQUAMOUS CELL; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KERATOSIS, ACTINIC; QUALITY OF LIFE; SKIN NEOPLASMS;

EID: 84929461706     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000366530     Document Type: Article

References (45)

1. Esmann S, Jemec GB: Management of actinic keratosis patients: a qualitative study. J Dermatolog Treat 2007; 18:53-58.
2. Kalivas J: Cryosurgery of actinic keratoses: the patient's perspective. Dermatol Surg 1996; 22:486.
3. Esmann S, Jemec GB: Patients' perceptions of topical treatments of actinic keratosis. J Dermatolog Treat 2014; 25: 375-379.
4. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-216.
5. Pflugfelder A, Welter AK, Leiter U, Weide B, Held L, Eigentler TK, Dirschka T, Stockfleth E, Nashan D, Garbe C; German Dermatologic Cooperative Oncology Group: Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. J Eur Acad Dermatol Venereol 2012; 26:48-53.
6. Hadley J, Tristani-Firouzi P, Hull C, Florell S, Cotter M, Hadley M: Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses. Dermatol Surg 2012; 38:722-727.
7. Gholam P, Kroehl V, Enk AH: Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis. Dermatology 2013; 226: 253-259.
8. Waalboer-Spuij R, Nijsten TE: A review on quality of life in keratinocyte carcinoma patients. G Ital Dermatol Vene-reol 2013; 148:249-254.
9. Brown BC, McKenna SP, Siddhi K, Mc-Grouther DA, Bayat A: The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 2008; 61:1049-1058.
10. Esmann S, Jemec GB: Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol 2011; 91:328-332.
11. Matusiak L, Bieniek A, Szepietowski JC: Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90:264-268.
12. Schmid-Ott G, Kuensebeck HW, Jaeger B, Werfel T, Frahm K, Ruitman J, Kapp A, Lamprecht F: Validity study for the stigmatization experience in atopic der matitis and psoriatic patients. Acta Derm Venereol 1999; 79:443-447.
13. Joachim G, Acorn S: Stigma of visible and invisible chronic conditions. J Adv Nurs 2000; 32:243-248.
14. Neil JA: The stigma scale: measuring body image and the skin. Plast Surg Nurs 2001; 21:79-82, 87.
15. Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D: Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002; 147:736-742.
16. Peters EM: Psychological support of skin cancer patients. Br J Dermatol 2012; 167(suppl 2):105-110.
17. Stockfleth E, Ferrandiz C, Grob JJ, Leigh I, Pehamberger H, Kerl H; European Skin Academy: Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18:651-659.
18. Tran DT, Salmon R: Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes. Australas J Dermatol 2011; 52:195-201.
19. Tierney EP, Eide MJ, Jacobsen G, Ozog D: Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther 2008; 10:81-86.
20. Esmann S, Vinding GR, Christensen KB, Jemec GB: Assessing the influence of actinic keratosis on patients' quality of life: the AKQoL questionnaire. Br J Dermatol 2013; 168: 277-283.
21. Erratum in: Br J Dermatol 2013; 168:914.
22. Gholam P, Denk K, Sehr T, Enk A, Hartmann M: Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010; 63:213-218.
23. Gholam P, Weberschock T, Denk K, Enk A: Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology 2011; 222:358-362.
24. van Laarhoven AI, Walker AL, WilderSmith OH, Kroeze S, van Riel PL, van de Kerkhof PC, Kraaimaat FW, Evers AW: Role of induced negative and positive emotions in sensitivity to itch and pain in women. Br J Dermatol 2012; 167:262-269.
25. Albrecht GL, Devlieger PJ: The disability paradox: high quality of life against all odds. Soc Sci Med 1999; 48:977-988.
26. Halldin CB, Gonzalez H, Wennberg AM, Lepp M: Patients' experiences of pain and pain relief during photodynamic therapy on actinic keratoses: an interview study. Acta Derm Venereol 2013; 93:433-437.
27. Storm A, Andersen SE, Benfeldt E, Se-rup J: One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 2008; 59:27-33.
28. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC; International Psoriasis Council: Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 2008; 59:1009-1016.
29. Ali SM, Brodell RT, Balkrishnan R, Feld-man SR: Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol 2007; 143:912-915.
30. Lee IA, Maibach HI: Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol 2006; 7:231-236.
31. Yentzer B, Hick J, Williams L, Inabinet R, Wilson R, Camacho FT, Russell GB, Feldman SR: Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol 2009; 145:203-205.
32. Stockfleth E, Zwingers T, Willers C: Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol 2012; 22:370-374.
33. Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP: Matching patients with therapy. Cutis 2004; 74: 5-8.
34. MacKie RM: Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe. J Eur Acad Dermatol Venereol 2004; 18:552-555.
35. Fife BL: The conceptualization of meaning in illness. Soc Sci Med 1994; 38:309-316.
36. Fife BL: The role of constructed meaning in adaptation to the onset of life-threatening illness. Soc Sci Med 2005; 61: 2132-2143.
37. Wenger E: Communities of Practice: Learning, Meaning, and Identity. Cambridge, Cambridge University Press, 1999.
38. Prior SM, Fenwick KD, Peterson JC: Adolescents' reasons for tanning and appearance motives: a preliminary study. Body Image 2014; 11:93-96.
39. Cafri G, Thompson JK, Jacobsen PB, Hillhouse J: Investigating the role of appearance-based factors in predicting sunbathing and tanning salon use. J Be-hav Med 2009; 32:532-544.
40. Robinson JK, Baker MK, Hillhouse JJ: New approaches to melanoma prevention. Dermatol Clin 2012; 30:405-412.
41. Keesling B, Friedman HS: Psychosocial factors in sunbathing and sunscreen use. Health Psychol 1987; 6:477-493.
42. Sheehan DJ, Lesher JL Jr: The effect of sunless tanning on behavior in the sun: a pilot study. South Med J 2005; 98: 1192-1195.
43. Sahn RE, McIlwain MJ, Magee KH, Veledar E, Chen SC: A cross-sectional study examining the correlation between sunless tanning product use and tanning beliefs and behaviors. Arch Dermatol 2012; 148:448-454.
44. Winterbottom A, Harcourt D: Patients' experience of the diagnosis and treatment of skin cancer. J Adv Nurs 2004; 48:226-233.
45. Brown JE, King MT, Butow PN, Dunn SM, Coates AS: Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models. Qual Life Res 2000; 9:75-85.